- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06077630
Non-attendance Prediction Models to Pediatric Outpatient Appointments
Non-attendance to Pediatric Outpatient Appointments: Prevalence, Associated Factors and Prediction Models
Non-attendance to pediatric outpatient appointments is a frequent and relevant public health problem.
Using different approaches it is possible to build non-attendance predictive models and these models can be used to guide strategies aimed at reducing no-shows. However, predictive models have limitations and it is unclear which is the best method to generate them. Regardless of the strategy used to build the predictive model, discrimination, measured as area under the curve, has a ceiling around 0.80. This implies that the models do not have a 100% discrimination capacity for no-show and therefore, in a proportion of cases they will be wrong. This classification error limits all models diagnostic performance and therefore, their application in real life situations. Despite all this, the limitations of predictive models are little explored.
Taking into account the negative effects of non-attendance, the possibility of generating predictive models and using them to guide strategies to reduce non-attendance, we propose to generate non-attendance predictive models for outpatient appointments using traditional logistic regression and machine learning techniques, evaluate their diagnostic performance and finally, identify and characterize the population misclassified by predictive models.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- pediatric outpatient appointments
Exclusion Criteria:
- appointments generated for system benchmarking or appointments with missing data
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Attended appointments
An appointment scheduled by a patient that was attended
|
There is no intervention, observational study
|
|
Not-attended appointments
An appointment scheduled by a patient that was not-attended, regardless of the cause
|
There is no intervention, observational study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Predictive Model non-attendance discrimination
Time Frame: 12 months
|
Area Under the ROC Curve
|
12 months
|
|
Predictive Model non-attendance calibration
Time Frame: 12 months
|
Calibration chart with predicted vs observed probability.
|
12 months
|
|
Predictive Model non-attendance diagnostic performance
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Characterize the appointments misclassified by predictive models (FP)
Time Frame: 12 months
|
False positive appointments prevalence
|
12 months
|
|
Characterize the appointments misclassified by predictive models (FN)
Time Frame: 12 months
|
False negative appointments prevalence
|
12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mariano Ibarra, MD, Mag, Hospital General de Niños Pedro de Elizalde
- Principal Investigator: Diego H Giunta, MD, MPH, PhD, Hospital Italiano de Buenos Aires
- Principal Investigator: Arda Yilal, Engineer, Karolinska Institutet
- Principal Investigator: Leticia Peroni, MD, Mag, Hospital Italiano de Buenos Aires
- Principal Investigator: Lucia Perez, MD, Hospital Italiano de Buenos Aires
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 4084
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.